These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26485863)

  • 41. [Optimal surveillance intensity of cystoscopy in intermediate-risk non-muscle invasive bladder cancer].
    Wang F; Qin CP; DU YQ; Liu SJ; Li Q; Xu T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):669-673. PubMed ID: 35950390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data.
    Burger M; Grossman HB; Droller M; Schmidbauer J; Hermann G; Drăgoescu O; Ray E; Fradet Y; Karl A; Burgués JP; Witjes JA; Stenzl A; Jichlinski P; Jocham D
    Eur Urol; 2013 Nov; 64(5):846-54. PubMed ID: 23602406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of hexaminolevulinate based flexible and rigid fluorescence cystoscopy with rigid white light cystoscopy in bladder cancer: results of a prospective Phase II study.
    Witjes JA; Moonen PM; van der Heijden AG
    Eur Urol; 2005 Mar; 47(3):319-22. PubMed ID: 15716194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year.
    Guney S; Guney N; Canogullari Z; Ergenekon E
    Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Innovations in the endoscopic management of bladder cancer: is the era of white light cystoscopy over.
    Soria F; Gurioli A; Peraldo F; Oderda M; Giona S; Ambrosini E; Frea B; Gontero P
    Urologia; 2013 Jun; 80 Spec No 1():1-8. PubMed ID: 23813287
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective randomized crossover trial of lubricant gel against an anaesthetic gel for outpatient cystoscopy.
    Chitale S; Hirani M; Swift L; Ho E
    Scand J Urol Nephrol; 2008; 42(2):164-7. PubMed ID: 17926205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The impact of regular biopsy in the first cystoscopic follow-up and other predictors on the recurrence of superficial bladder tumors.
    Chang YH; Chuang CK; Pang ST; Wu CT; Chuang KL; Liao SK
    Chang Gung Med J; 2010; 33(2):174-87. PubMed ID: 20438670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experience.
    Rayn KN; Hale GR; Bloom JB; Gold SA; Carvalho FLF; Mehralivand S; Czarniecki M; Wood BJ; Merino MJ; Choyke P; Türkbey B; Pinto PA; Agarwal PK
    Diagn Interv Radiol; 2018 Sep; 24(5):316-320. PubMed ID: 30211685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hexaminolevulinate hydrochloride blue-light flexible cystoscopy in the detection and follow-up of nonmuscle-invasive bladder cancer: cost consequences during outpatient surveillance in Sweden.
    Dansk V; Malmström PU; Bläckberg M; Malmenäs M
    Future Oncol; 2016; 12(8):1025-38. PubMed ID: 26975197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-dose BCG instillations in the treatment of stage T1 grade 3 bladder tumours: recurrence, progression and success.
    Lebret T; Gaudez F; Hervé JM; Barré P; Lugagne PM; Botto H
    Eur Urol; 1998; 34(1):67-72. PubMed ID: 9676417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outpatient diode laser treatment of intermediate-risk non-invasive bladder tumors without sedation: efficacy, safety and economic analysis.
    Hermann GG; Mogensen K; Rosthøj S
    Scand J Urol; 2018 Jun; 52(3):194-198. PubMed ID: 29607745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Routine use of ultrasound and flexible cystoscopy in the control of benign bladder tumours.
    Knoblauch NO; Rønning H; Knudsen P; Lund L; Nielsen KT
    Int Urol Nephrol; 1994; 26(4):431-6. PubMed ID: 8002216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical results of the transurethreal resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolevulinic acid.
    Filbeck T; Roessler W; Knuechel R; Straub M; Kiel HJ; Wieland WF
    J Endourol; 1999 Mar; 13(2):117-21. PubMed ID: 10213106
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnosis and management of superficial bladder cancer.
    Amling CL
    Curr Probl Cancer; 2001; 25(4):219-78. PubMed ID: 11514784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infiltrative lamina propria invasion pattern as an independent predictor for cancer-specific and overall survival of instillation treatment-naïve stage T1 high-grade urothelial bladder cancer.
    Otto W; van Rhijn BW; Breyer J; Bertz S; Eckstein M; Mayr R; Lausenmeyer EM; Denzinger S; Burger M; Hartmann A
    Int J Urol; 2018 May; 25(5):442-449. PubMed ID: 29473226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiparametric Magnetic Resonance Imaging in the follow-up of non-muscle-invasive bladder tumors after intravesical instillations: a promising tool.
    Klein C; Brunelle S; Illy M; De Luca V; Doisy L; Lannes F; Sypre D; Branger N; Maubon T; Rybikowski S; Guérin M; Gravis G; Walz J; Pignot G
    World J Urol; 2024 Mar; 42(1):178. PubMed ID: 38507101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urine cytology in the follow-up of patients with transitional cell carcinoma of the urinary bladder: is that enough as a single method?
    Raica M; Miclea F; Ioiart I; Minciu R; Drăgan P
    Rom J Morphol Embryol; 1998; 44(1-4):173-8. PubMed ID: 15678859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of the bladder-tumour associated analyte test to determine the type of cystoscopy in the follow-up of patients with bladder cancer. The United Kingdom and Eire Bladder Tumour Antigen Study Group.
    Br J Urol; 1997 Mar; 79(3):362-6. PubMed ID: 9117214
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
    Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
    J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Instillation of anesthetic gel is no longer necessary in the era of flexible cystoscopy: a crossover study.
    Kobayashi T; Nishizawa K; Mitsumori K; Ogura K
    J Endourol; 2004 Jun; 18(5):483-6. PubMed ID: 15253827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.